Evidence map›Paper›PMID 38155323›Full record

ArticleEndocrine2024

Determinants of the uptake of the uncinate process of pancreas in

Lucas Jallet, Wadi' Othmani, Marine Perrier, David Morland

Open access · hybridAbstract read
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lucas JalletService de Médecine Nucléaire, Institut Godinot, Reims, France.
Wadi' OthmaniService de Médecine Nucléaire, Institut Godinot, Reims, France.
Marine PerrierHépato-Gastroentérologie et Cancérologie digestive, Centre Hospitalier Universitaire de Reims, Reims, France.
David MorlandService de Médecine Nucléaire, Institut Godinot, Reims, France. david.morland@reims.unicancer.fr.ORCID 0000-0001-8738-4841
Institut Jean Godinot · FRCentre Hospitalier Universitaire de Reims · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposean increased uptake of the uncinate process of pancreas (UPP) has been described in about one-third of somatostatin receptor imaging procedures and may hinder image interpretation. The determinants of this uptake are however poorly understood. The aim of this study was to investigate the impact of cold somatostatin analogues (cSA) on UPP

methodsall adult patients who performed a

results82 patients were included. UPP uptake was significantly lower in patients treated with cSA (OR 0.27, p = 0.015 in multivariate analysis), with a lower SUVmax (4.97 vs. 8.81, p = 0.001). No significant result was found regarding diabetic status or age.

conclusioncold somatostatin analog treatment decreased the physiological UPP uptake in

Indexed as

OctreotideOrganometallic CompoundsPancreasPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeuroendocrine TumorsRetrospective StudiesGa(III)-DOTATOCOctreotideOrganometallic CompoundsHealthy organsNeuroendocrinePETSomatostatin

Identifiers

PMID38155323
PMCPMC11246289
OpenAlexW4390338745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.